VESIcare

PreclinicalSmall molecule

Astellas

VESIcare is one of 10 small molecule programs targeting Prostatectomy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ProstatectomyTerminated

ProstatectomyPreclinical

Terminated

Competition

Competitive Landscape

11 competitors in Prostatectomy

#DrugCompanyPhaseTrials

Leuprorelin

Takeda

Phase 3

1 2

Sutent

Pfizer

Phase 2

1 3

Firmagon

Ferring

Phase 2

3 4

LHRH Agonist

Roche

Phase 2

2 5

Flomax

Sanofi

Preclinical

1 6

Ramosetron

Astellas

Preclinical

1 7

ARN-509

AAragon Pharmaceuticals, Inc.

Phase 2

1 8

Acetaminophen/ibuprofen

SSeoul National University Hospital

Preclinical

1 9

VESIcare

Astellas

Preclinical

2 10

Belladonna and Opium

UUniversity of Washington

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prostatectomy2 trials

Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy

Terminated·UUniversity of California, Irvine·N/A·NCT00581061·13 enrolled

Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)

Completed·UUniversity of California, Irvine·N/A·NCT01215721·40 enrolled

Overactive Bladder2 trials

Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder

Terminated·LLahey Clinic·Phase 3·NCT00821184·12 enrolled

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)

Completed· Astellas logo

Astellas·Phase 3·NCT00454896·739 enrolled

Multiple Sclerosis1 trial

Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple Sclerosis

Terminated·BBrigitte Schürch·Phase 4·NCT04819360·1 enrolled

CAR1 trial

Post Marketing Survey of Vesicare in Japan

Completed· Astellas logo

Astellas··NCT01489709·1,160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for VESIcare. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — VESIcare compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for VESIcare. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Astellas company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Astellas

VESIcare

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prostatectomy2 trials

Overactive Bladder2 trials

Multiple Sclerosis1 trial

CAR1 trial

References

Drug Info

Quick Facts

Related News